3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Warts
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukopenia
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infections
1
Immunologic Deficiency Syndromes
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Agammaglobulinemia
1
Acquired Immunodeficiency Syndrome
1
Interventions
fludarabine
7
Whole-Body Irradiation
6
Cyclophosphamide
6
venetoclax
5
fludarabine phosphate
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Busulfan
4
asciminib
3
gilteritinib
2
blinatumomab
2
aldesleukin
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Interleukin-2
2
Idarubicin
2
Cytarabine
2
Bone Marrow Transplantation
2
Azacitidine
2
ponatinib
1
nilotinib
1
nicotinamide-beta-riboside
1
methanesulfonic acid
1
enasidenib
1
Thiotepa
1
Stem Cell Transplantation
1
Social Determinants of Health
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
plerixafor
×
1 year
×
Clear all
No trials found.